bovin
respiratori
syncyti
viru
brsv
import
caus
respiratori
diseas
among
calv
danish
cattl
industri
experiment
brsv
infect
model
use
studi
pathogenesi
diseas
calv
broncho
alveolar
lung
lavag
bal
perform
jersey
calv
experiment
infect
brsv
given
mock
inoculum
presenc
cytokin
tumor
necrosi
factor
tnfa
detect
captur
elisa
tnfa
detect
infect
anim
amount
tnfa
calv
kill
post
inocul
day
pid
low
level
uninfect
control
anim
larg
amount
tnfa
detect
pid
maximum
level
tnfa
reach
pid
smaller
amount
tnfa
seen
pid
high
level
tnfa
appear
day
sever
lung
lesion
clinic
sign
obviou
amount
brsvantigen
greatest
although
pasteurellacea
isol
brsvinfect
calv
calv
treat
antibiot
whole
period
infect
well
brsvinfect
calv
free
bacteria
reach
level
tnfa
anim
bacteria
isol
lung
conclud
quantiti
tnfa
produc
lung
calv
veterinari
immunolog
immunopatholog
abbrevi
pid
post
inocul
day
brsv
bovin
respiratori
syncyti
viru
mock
mock
inoculum
bal
broncho
alveolar
lung
lavag
tnfa
tumor
necrosi
factora
increas
pulmonari
secret
tumor
necrosi
factora
calv
experiment
infect
bovin
respiratori
syncyti
viru
enzoot
pneumonia
widespread
diseas
cattl
popul
throughout
world
bryson
denmark
bovin
respiratori
syncyti
viru
brsv
play
crucial
role
respiratori
diseas
complex
lead
substanti
loss
within
calf
rear
industri
brsv
singlestrand
rna
viru
belong
genu
pneumoviru
subfamili
pneumovirina
famili
paramyxovirida
murphi
et
al
viru
close
relat
human
respiratori
syncyti
viru
hrsv
collin
et
al
cattl
brsv
induc
diseas
rang
fatal
bronchointerstiti
pneumonia
subclin
infect
bryson
calv
get
serious
ill
brsv
infect
develop
sever
cough
tachypnea
dyspnea
mucopurul
nasal
discharg
high
fever
kimman
et
al
belknap
gross
lesion
appear
larg
area
consolid
tissu
cranioventr
part
lung
bronchi
bronchioli
often
mucopurul
exud
interstiti
edema
may
seen
lobe
wherea
emphysema
typic
locat
diaphragmat
lobe
kimman
et
al
bryson
microscop
consist
epitheli
lesion
bronchi
bronchiol
alveoli
neutrophil
macrophag
frequent
multinuclear
syncytia
well
hyalin
membran
found
also
evid
bronchiolar
repair
includ
epitheli
hyperplasia
organis
exud
observ
fairli
earli
cours
infect
kimman
et
al
bryson
immunostain
perform
lung
tissu
indic
brsv
locat
cranioventr
lobe
case
rare
caudal
part
diaphragmat
lobe
kimman
et
al
elli
et
al
viuff
et
al
similar
clinic
sign
patholog
appear
brsvinfect
calv
hrsvinfect
infant
notic
baker
henc
studi
brsvinfect
calv
also
contribut
valuabl
inform
diseas
infant
today
avail
treatment
prophylact
precaut
diseas
far
optim
fact
vaccin
hrsv
still
avail
children
collin
et
al
therefor
great
effort
made
studi
immun
respons
pathogenesi
viral
infect
rumin
kimman
belknap
et
al
sinc
lesion
present
area
lung
littl
viru
detect
one
sever
immunopatholog
mechan
assum
involv
diseas
baker
kimman
moreov
import
differ
subpopul
leukocyt
lung
infect
investig
kimman
taylor
et
al
particular
alveolar
macrophag
phagocytis
pathogen
secret
immunoregulatori
cytokin
attract
attent
human
murin
infect
hrsv
vitro
produc
larg
amount
cytokin
tumor
necrosi
factora
tnfa
panuska
et
al
becker
et
al
today
accumul
data
vivo
investig
indic
tnfa
implic
pathogenesi
diseas
isol
infant
suffer
acut
rsv
infect
found
express
tnfa
protein
cellassoci
manner
midulla
et
al
moreov
matsuda
et
al
demonstr
presenc
tnfa
nasal
discharg
hrsvinfect
infant
murin
hrsvmodel
high
level
bioactiv
tnfa
found
lung
sera
hrsvinfect
balbc
mice
post
inocul
day
pid
hay
et
al
addit
tnfa
shown
possess
antivir
effect
hrsv
vitro
cirino
et
al
merolla
et
al
well
mice
vivo
neuzil
et
al
therefor
cytokin
may
also
involv
immun
defens
direct
rsv
infect
henc
tnfa
seem
import
cytokin
look
lung
brsvinfect
calv
aim
studi
investig
whether
brsv
induc
secret
tnfa
lung
infect
calv
match
clinic
sign
patholog
chang
appear
brsvantigen
lung
anim
knowledg
submit
evid
tnfa
present
lung
brsvinfect
calv
third
cell
cultur
passag
brsv
isol
design
use
inoculum
experiment
infect
calv
origin
propag
viru
describ
larsen
et
al
mock
inoculum
consist
fetal
calf
lung
cell
fbl
cell
grown
frozen
fbl
cell
viru
propag
inocula
test
free
bovin
viru
diarrhea
viru
bvdv
bovin
viru
bovin
adeno
viru
bav
bovin
corona
viru
bcv
bovin
entero
viru
bev
infecti
bovin
rhinotrach
viru
ibrv
bovin
reo
viru
bacteria
bovin
mycoplasma
experiment
model
brsv
infect
calv
prepar
use
studi
pathogenesi
diseas
day
old
male
jersey
calv
purchas
close
herd
rear
isol
unit
follow
normal
manag
procedur
calv
eight
twentyon
week
old
calv
inocul
min
aerosol
exposur
follow
intratrach
inject
viral
inoculum
tissu
cultur
infecti
dose
tcid
brsv
rout
mock
inocula
dilut
administ
way
viral
inoculum
calv
experi
test
free
infect
bvdv
inocul
inocul
viru
gener
health
statu
calv
monitor
onset
degre
clinic
sign
follow
daili
total
calv
differ
experi
includ
studi
twentythre
anim
given
brsv
inoculum
rest
calv
receiv
mock
inoculum
calv
kill
pid
four
calv
kill
pid
treat
system
broad
spectrum
antibiot
baytril
mgkg
bayer
start
day
inocul
brsv
throughout
experi
lung
immedi
remov
anim
exsanguin
photograph
taken
ventral
dorsal
side
lung
extent
consolid
lung
tissu
score
score
given
lung
complet
free
lung
lesion
lung
spot
consolid
lung
tissu
lung
lung
lung
consolid
tissu
score
given
lung
tissu
cranial
medial
accessori
lobe
least
third
diaphragmat
lobe
consist
consolid
tissu
bal
perform
left
lung
bronchi
lung
ml
eagl
minimum
essenti
medium
mem
collect
supplement
equal
amount
medium
contain
iu
penicillin
gml
mg
streptomycin
per
ml
amphotericin
cytokin
viral
examin
immedi
snapfrozen
liquid
nitrogen
wherea
cytospin
prepar
kept
process
within
h
cell
centrifug
shandon
cytospin
centrifug
rpm
onto
coat
slide
superfrost
air
dri
min
ethanol
min
rule
possibl
agent
caus
diseas
lesion
lung
tissu
right
lung
test
presenc
bav
bcv
antigen
enzymelink
immunosorb
assay
elisa
addit
lung
tissu
examin
viabl
bev
ibrv
bovin
reo
viru
bav
bvdv
supernat
minc
lung
tissu
transfer
monolay
bovin
kidney
cell
cytopath
effect
cpe
combin
techniqu
use
presenc
also
tissu
sampl
taken
lung
spleen
liver
cultur
bacteria
final
bronchial
swab
analyz
presenc
mycoplasma
spp
danish
veterinari
laboratori
danish
veterinari
institut
viru
research
carri
analys
two
gram
lung
tissu
collect
nine
differ
predetermin
area
left
lung
repres
dorsal
medial
ventral
part
lobe
lung
tissu
store
examin
presenc
brsvantigen
indirect
antigen
elisa
et
al
prepar
perform
sum
titer
nine
sampl
use
measur
level
brsvantigen
lung
tissu
lung
supernat
lung
tissu
soak
mem
investig
infecti
brsv
et
al
prepar
sampl
transfer
fbl
cell
grown
cpe
occur
two
cell
passag
made
follow
indirect
test
use
hyperimmun
guinea
pig
serum
brsv
fitc
conjug
rabbit
antiguinea
pig
antibodi
dako
visual
brsv
cell
cultur
detect
brsvantigen
bal
cell
done
immunocytochemistri
cytospin
prepar
incub
min
trisbuff
salin
tb
tri
nacl
ph
follow
min
block
tb
swine
serum
slide
incub
h
bovin
biotinyl
hyperimmun
serum
brsv
dilut
tb
contain
swine
serum
follow
h
incub
streptavidinalkalin
phosphatas
complex
dako
three
wash
tb
perform
incub
step
final
viru
posit
cell
visual
fast
red
substrat
kementec
harri
haematoxylen
counterstain
cytospin
prepar
fbl
cell
infect
brsv
use
posit
control
noninfect
fbl
cell
bal
cell
anim
test
neg
brsv
serv
neg
control
immunostain
evalu
light
microscopi
slide
given
one
follow
score
viru
posit
cell
viru
posit
cell
viru
posit
cell
viru
posit
cell
viru
posit
cell
viru
posit
cell
immunocytochemistri
also
use
studi
presenc
tnfa
bal
cell
rehydr
block
perform
describ
cytospin
prepar
bal
cell
incub
monoclon
antibodi
tnfa
elli
et
al
dilut
tb
contain
swine
serum
h
follow
min
incub
envis
dako
visual
fast
red
substrat
kementec
isotyp
match
antibodi
igg
dako
dilut
appli
neg
control
immunocytochemistri
procedur
wherea
cytospin
prepar
freshli
isol
bal
cell
uninfect
calv
run
neg
control
cell
cytospin
prepar
bam
stimul
h
endotoxin
mgml
e
coli
sigma
use
posit
control
presenc
tnfa
lung
examin
captur
antigen
elisa
monoclon
polyclon
antibodi
use
detect
tnfa
describ
elli
et
al
maxisorb
immunopl
nunc
coat
h
monoclon
antibodi
tnfa
dilut
coat
buffer
mm
nahco
mm
na
co
ph
plate
wash
six
time
tb
contain
tween
tbst
triplic
lung
lavag
dilut
tbst
gelatin
tbstg
transfer
well
left
overnight
follow
day
plate
wash
tbst
incub
h
polyclon
rabbit
antitnfa
pool
dilut
tbstg
follow
wash
step
h
incub
period
biotinyl
goat
antirabbit
h
l
chain
zyme
dilut
anoth
wash
step
h
incub
period
streptavidinalkalin
phosphatas
gibcobrl
dilut
final
pnitrophenyl
phosphatesubstr
gibcobrl
ad
well
incub
min
plate
read
nm
use
nm
refer
dilut
recombin
bovin
tnfa
cibageigi
use
standard
plain
medium
use
neg
control
odvalu
standard
plot
ngml
tnfa
dilut
occur
lung
wash
procedur
taken
account
calcul
amount
tnfa
twotail
student
ttest
use
compar
amount
tnfa
present
brsvinfect
calv
calv
given
mock
inoculum
amount
tnfa
present
brsvinfect
calv
treat
treat
antibiot
pid
amount
tnfa
brsvinfect
calv
without
bacteria
lung
pid
data
logtransform
achiev
normal
distribut
p
consid
base
temperatur
respir
rate
record
day
anim
kill
clinic
sign
appear
calv
kill
day
mild
cough
bodi
temperatur
respiratori
rate
min
within
normal
rang
tabl
sever
clinic
sign
seen
calv
kill
pid
exhibit
depress
mucopurul
nasal
discharg
sever
cough
dyspnea
furthermor
respiratori
rate
rang
min
monitor
calv
kill
pid
febril
reaction
present
calv
pid
total
seven
nine
calv
kill
pid
eight
calv
kill
pid
reach
temperatur
one
calf
kill
pid
normal
temperatur
whole
period
calf
kill
pid
drop
pid
pid
result
shown
spot
dark
red
consolid
lung
tissu
seen
pid
lung
calv
infect
brsv
lesion
could
hardli
distinguish
subacut
chronic
lesion
seen
neg
control
calv
small
amount
mucopurul
discharg
present
bronchi
trachea
brsv
mockinocul
anim
lung
calv
given
score
pid
infect
calv
moder
sever
exud
bronchopneumonia
consolid
lung
tissu
score
averag
score
pid
pid
pid
fig
trachea
bronchi
contain
larg
amount
mucopurul
purul
discharg
addit
widespread
interstiti
edema
lobe
emphysema
found
especi
diaphragmat
lobe
affect
calv
bovin
viru
isol
lower
airway
calv
experi
mycoplasma
dispar
present
almost
everi
calf
includ
one
given
mock
inoculum
tabl
moreov
possibl
isol
mycoplasma
bovirhini
ureaplasma
simultan
individu
brsvinfect
calv
six
found
neg
mycoplasma
three
anim
treat
antibiot
tabl
bacteria
isol
brsvinfect
calv
pid
pid
calv
treat
antibiot
pid
calf
given
mock
inoculum
haemophilu
somnu
pasteurella
multocida
isol
two
calv
respect
brsvinfect
calv
kill
pid
total
brsv
titer
left
lung
calcul
sum
antigen
titer
measur
nine
differ
predetermin
spot
brsv
antigen
could
detect
pid
moder
valu
seen
pid
high
valu
appear
pid
pid
one
calf
kill
pid
one
kill
pid
neg
brsv
nine
test
site
amount
detect
antigen
decreas
low
level
pid
fig
infecti
brsv
could
transfer
lung
calv
fetal
calf
lung
cell
pid
pid
two
eight
calv
contain
infecti
brsv
pid
calv
neg
infecti
brsv
lung
tissu
howev
one
calf
infecti
viru
tabl
immunocytochemistri
use
detect
brsvantigen
within
balcel
brsvantigen
locat
neutrophil
alveolar
macrophag
epitheli
cell
amount
neutrophil
bal
increas
dramat
pid
actual
percentag
cell
popul
establish
mani
neutrophil
epitheli
cell
appear
clump
pid
brsvantigen
detect
cell
score
pid
amount
cell
contain
brsv
increas
score
cell
cytospin
wherea
least
score
cell
posit
pid
score
given
singl
anim
pid
number
brsv
posit
cell
declin
around
pid
score
brsv
posit
signal
appear
mockinocul
calv
tabl
b
neg
control
calv
bold
roman
given
mock
inoculum
c
respir
rate
measur
pid
calv
treat
antibiot
baytril
administr
daili
day
inocul
brsv
calv
kill
pid
e
temperatur
taken
pid
f
temperatur
taken
pid
g
infecti
brsv
found
lung
tissu
h
nd
done
amount
tnfa
found
lung
brsvinfect
calv
compar
uninfect
calv
p
demonstr
tabl
fig
detect
low
amount
ngml
tnfa
found
pid
cytokin
level
chang
dramat
pid
valu
rang
ng
ml
mean
ngml
increas
even
pid
bal
contain
ngml
mean
ngml
high
tnfa
valu
found
bal
three
four
calv
treat
antibiot
one
calf
affect
brsvinfect
rest
calv
group
neither
brsvantigen
tnfa
detect
bal
anim
tnfa
level
brsvinfect
calv
treat
antibiot
differ
tnfa
level
brsvinfect
calv
treat
antibiot
pid
p
b
also
tnfa
level
calv
p
multocida
h
somnu
isol
differ
p
b
calv
bacteria
detect
pid
lung
lavag
perform
two
anim
pid
contain
ngml
respect
gener
calv
high
level
brsvantigen
lung
tissu
fairli
larg
amount
tnfa
lung
wash
extrem
high
tnfa
valu
measur
two
calv
pid
p
multocida
isol
one
case
contrast
tnfa
found
small
amount
ngml
one
mockinocul
anim
pid
could
detect
remain
uninfect
control
calv
furthermor
bal
cell
four
brsvinfect
calv
kill
pid
examin
presenc
cellassoci
tnfa
immunocytochemistri
mani
bal
cell
posit
tnfa
cell
stain
intens
moder
cytokin
other
weakli
therefor
subpopul
cell
produc
tnfa
could
method
bal
cell
calv
stain
intens
brsvantigen
strongli
posit
tnfa
parallel
slide
isotyp
match
control
result
almost
background
stain
posit
signal
could
detect
minor
balcel
noninfect
calv
sever
experi
indic
antivir
cytokin
tnfa
involv
pathogenesi
rsvinfect
human
mice
panuska
et
al
neuzil
et
al
investig
tnfa
produc
lung
calv
infect
brsv
agreement
hay
et
al
found
studi
experiment
hrsvinfect
mice
demonstr
larg
amount
tnfa
produc
lung
calv
experiment
infect
brsv
contrast
studi
rsvstudi
perform
natur
host
furthermor
tnfa
measur
bal
brsv
infect
calv
like
bioactiv
sinc
result
elisa
correl
well
clone
bioassay
measur
bioactiv
tnfa
elli
et
al
cytokin
tnfa
known
attract
activ
neutrophil
granulocyt
lymphocyt
induct
cytokin
ohmann
et
al
chiang
et
al
persson
et
al
cytokin
also
shown
involv
mechan
lead
increas
permeabl
endothelium
zeckkapp
et
al
epithelium
lung
li
et
al
addit
tnfa
shown
inhibit
alveolar
type
ii
epitheli
cell
product
surfact
phospholipid
ariasdiaz
et
al
surfact
protein
wisp
et
al
pryhub
et
al
mechan
suggest
contribut
pathophysiolog
adult
respiratori
distress
syndrom
ard
ariasdiaz
et
al
therefor
biolog
effect
induc
tnfa
could
explain
presenc
purul
exud
edema
atelectasi
brsvinfect
lung
henc
suggest
high
level
tnfa
measur
pid
contribut
sever
lung
lesion
clinic
sign
accompani
brsv
infect
pid
sinc
p
haemolytica
p
multocida
capabl
induc
harm
cytokinerespons
lung
bienhoff
et
al
yoo
et
al
tnfa
measur
brsvinfect
calv
coinfect
pasteurellacea
spp
could
caus
bacteria
howev
data
suggest
brsv
capabl
induc
secret
tnfa
without
contribut
agent
inde
correl
presenc
infecti
agent
level
tnfa
case
high
level
tnfa
found
calv
larg
amount
brsv
antigen
lung
still
calv
high
level
brsv
antigen
moder
amount
tnfa
individu
data
shown
might
explain
kinet
tnfa
known
produc
degrad
rather
quickli
thu
level
cytokin
easili
chang
within
hour
adam
et
al
horadagoda
et
al
previous
alveolar
macrophag
shown
main
sourc
tnfa
lung
environ
warren
et
al
van
nhieu
et
al
howev
like
yoo
et
al
unabl
identifi
cell
respons
product
tnfa
lung
mani
bal
cell
includ
cell
debri
stain
posit
cytokin
immunocytochemistri
brsvinfect
anim
might
explain
fact
tnfa
also
appear
cellassoci
manner
partli
cytokin
bind
cell
via
receptor
ohmann
et
al
also
tnfa
exist
cell
surfac
membraneassoci
form
nii
et
al
compar
bovin
studi
yoo
et
al
rel
high
amount
tnfa
detect
studi
possibl
cellassoci
tnfa
includ
sinc
balcel
separ
lung
wash
suspens
frozen
anoth
potenti
contributor
tnfa
present
bal
airway
epithelium
although
alveoli
bronchioli
epitheli
cell
cultur
shown
secret
granulocyt
macrophag
stimul
factor
arnold
et
al
jiang
et
al
patel
et
al
infect
vitro
hrsv
controversi
exist
whether
cell
also
secret
tnfa
arnold
et
al
patel
et
al
viral
infect
immun
respons
consist
humor
cell
mediat
immun
respons
respons
clearanc
viru
brsv
infect
antibodi
shown
appear
brsvinfect
calv
pid
activ
matern
acquir
antibodi
clearanc
brsv
still
unclear
kimman
howev
investig
perform
taylor
et
al
indic
cytotox
tlymphocyt
could
particip
clearanc
brsv
infect
studi
calv
matern
antibodi
igg
brsv
inocul
brsv
igm
detect
pid
one
calf
data
shown
presenc
cytotox
tlymphocyt
lung
brsvinfect
calv
current
investig
within
group
addit
immun
respons
studi
perform
hrsvinfect
mice
cell
cultur
indic
tnfa
also
may
play
role
recoveri
infect
merolla
et
al
neuzil
et
al
studi
infecti
brsv
could
isol
lung
six
eight
brsvinfect
calv
day
pid
tnfa
reach
maximum
level
bal
impli
cytokin
could
play
import
role
antivir
immun
defens
brsv
infect
calv
time
immun
respons
brsv
fulli
establish
antivir
effect
tnfa
mainli
establish
tnfreceptor
induc
cytotox
bind
cytokin
wong
et
al
tartaglia
et
al
mechan
might
play
import
role
rsvinfect
sinc
vitro
studi
shown
tnfreceptor
secret
larg
amount
lung
epithelia
cell
infect
hrsv
arnold
et
al
interestingli
homolog
recent
discov
conserv
region
gprotein
rsv
domain
within
tnfreceptor
langedijk
et
al
therefor
one
could
specul
rsv
evolv
mechan
abl
interact
tnfa
therebi
inhibit
antivir
effect
cytokin
interfer
may
eventu
result
dramat
level
tnfa
found
lung
understand
pathogenesi
rsv
infect
essenti
treatment
reduc
lung
damag
clearli
futur
experi
involv
inhibit
tnfa
respons
earli
late
cours
viral
infect
intrapulmonari
administr
recombin
bovin
tnfa
monoclon
antibodi
tnfa
receptor
one
way
continu
studi
calv
moreov
drug
like
dexamethason
pentoxifyllin
known
inhibit
synthesi
tnfa
han
et
al
balibrea
et
al
could
administ
experiment
brsv
infect
